PNEUMA RESPIRATORY, INC.

Profile

Company Names

PNEUMA RESPIRATORY, INC.

Addresses

870 STATE FARM ROAD, SUITE 103-B, BOONE, NC 28607

255 APPALACHIAN DRIVE, BOONE, NC 28607

Phone Numbers

(828) 434-6433
(828) 772-2602

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

NORTH CAROLINA

Total Amount Raised:

$41,078,307.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2026-06-18 
$3,570,115.00 
INDEFINITE 
INDEFINITE 
Equity 
9
2025-02-10 
$3,304,000.00 
$3,304,000.00 
$0.00 
Debt 
8
2024-12-31 
$2,996,000.00 
INDEFINITE 
INDEFINITE 
Debt 
7
2024-11-29 
$2,996,000.00 
$2,996,000.00 
$0.00 
Debt 
6
2023-06-20 
$7,340,000.00 
INDEFINITE 
INDEFINITE 
Equity 
5
2020-08-21 
$429,585.00 
$429,585.00 
$0.00 
 
4
2020-06-18 
$437,794.00 
$3,000,000.00 
$2,562,206.00 
Equity 
3
2019-07-15 
$6,898,219.00 
$10,000,050.00 
$3,101,831.00 
Equity 
2
2019-02-25 
$4,999,906.00 
$4,999,906.00 
$0.00 
Equity 
1
2018-03-13 
$8,106,688.00 
$15,000,000.00 
$6,893,312.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
A. 
GIMIGLIANO 
EXECUTIVE OFFICER
FARNKH 
 
HAMEED 
DIRECTOR
FARRUKH 
 
HAMEED 
DIRECTOR
C. 
ERIC 
HUNTER 
EXECUTIVE OFFICER, DIRECTOR
JOCELYN 
 
HUNTER 
EXECUTIVE OFFICER
J. 
KNOX 
MORGAN 
DIRECTOR
JAY 
PHILLIP 
MORGAN 
DIRECTOR
WALTER 
E. 
ROBB 
DIRECTOR
WALTER 
L. 
ROBB 
DIRECTOR
MAY 
 
SHEN 
EXECUTIVE OFFICER
DOUGLAS 
E. 
SINGLETON 
DIRECTOR
J. 
KNOX 
SINGLETON 
DIRECTOR
DOUGLAS 
E. 
STONER 
DIRECTOR
SALLY 
 
YANCHUS 
EXECUTIVE OFFICER
WEI 
 
ZHENG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-29 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-10 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-10 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-15 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2020-08-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-15 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-15 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-07-15 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2019-02-25 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-03-13 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-03-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#